Dr. John Lewis is a Professor in the Department of Oncology at the University of Alberta and the Bird Dogs Chair in Translational Oncology. Dr. Lewis’ research interests include translational prostate cancer research, and the Lewis Lab utilizes real-time intravital imaging of the tumour microenvironment to learn about the critical steps of cancer progression, including the growth of new Read more about Dr. John Lewis at #CCRC2023[…]
Dr. Trevor Dummer will be attending the Canadian Cancer Research Conference. Dr. Dummer is the co-Scientific Director for CanPath, an Associate Professor at the School of Population and Public Health at the University of British Columbia, the Canadian Cancer Society Chair in Primary Prevention, and Affiliated Scientist, BC Cancer. Dr. Dummer’s research interests include how the Read more about Dr. Trevor Dummer and Mohadeseh Ahmadi at #CCRC2023[…]
Dr. Philip Awadalla, Scientific Director of CanPath, and Patient Partner/Atlantic PATH participant, Pauline McIntyre, will chair a panel at the Canadian Cancer Research Conference, “CanPath: Canada’s Largest Population Laboratory for Cancer Research” on Monday, November 13th at 11:40 AST. Presenters include Dr. Dylan O’Sullivan, Dr. Samina Abidi, Dr. Sara Nejatinamini, and Dr. Vikki Ho. Dr. Dylan O’Sullivan is Read more about CanPath at #CCRC2023: Canada’s Largest Population Laboratory for Cancer Research[…]
Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: Read more about Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19[…]
Congratulations to our colleagues, Dr. Jacob Nearing, Dr. Vanessa DeClercq and Dr. Morgan Langille on their new microbiome publication!! “Investigating the Oral Microbiome in Retrospective and Prospective Cases of Prostate, Colon and Breast Cancer” utilizes saliva samples from Atlantic PATH and Alberta’s Tomorrow Project to consider potential biomarkers for cancer. Link to article in Nature Read more about New Microbiome Publication[…]